New England Journal of Medicine , 379 (22), 21402150
Cyanocobalamin is added as nutritional support, as B12 deficiency risk may increase with GLP-1-mediated dietary restriction and reduced intrinsic factor-dependent absorption
While inflammation is present, it is typically less severe than in Hunner-type IC, and patients may experience mild inflammation or an increase in mast cells, which contribute to discomfort
Although it has been the subject of scientific study for decades, it has not received formal approval as a pharmaceutical agent and is not recognized for clinical use
1A and B), promotes the efficacy of lactate functionalized nanoparticles in drug delivery
Key ingredient Formulated with Glutathione Carnosine Peptide (1%) to defend against glycation and oxidative stress for visibly firmer skin, paired with Resveratrol (2%) for powerful antioxidant protection